Source: Wikipedia, the free encyclopedia.
-
1a0l: HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE
-
1lto: Human alpha1-tryptase
-
2bm2: HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE
-
2f9n: Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin
-
2f9o: Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G
-
2f9p: Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin
-
2fpz: Human tryptase with 2-amino benzimidazole
-
2fs8: Human beta-tryptase II with inhibitor CRA-29382
-
2fs9: Human beta tryptase II with inhibitor CRA-28427
-
2fww: human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme
-
2fxr: human beta tryptase II complexed with activated ketone inhibitor CRA-29382
-
2gdd: Human beta II tryptase with inhibitor CRA-27592
1a0l: HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE
1lto: Human alpha1-tryptase
2bm2: HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE
2f9n: Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leupeptin
2f9o: Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G
2f9p: Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptin
2fpz: Human tryptase with 2-amino benzimidazole
2fs8: Human beta-tryptase II with inhibitor CRA-29382
2fs9: Human beta tryptase II with inhibitor CRA-28427
2fww: human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme
2fxr: human beta tryptase II complexed with activated ketone inhibitor CRA-29382
2gdd: Human beta II tryptase with inhibitor CRA-27592
